74 related articles for article (PubMed ID: 22879062)
41. Related to testes-specific, vespid, and pathogenesis protein-1 (RTVP-1) is overexpressed in gliomas and regulates the growth, survival, and invasion of glioma cells.
Rosenzweig T; Ziv-Av A; Xiang C; Lu W; Cazacu S; Taler D; Miller CG; Reich R; Shoshan Y; Anikster Y; Kazimirsky G; Sarid R; Brodie C
Cancer Res; 2006 Apr; 66(8):4139-48. PubMed ID: 16618735
[TBL] [Abstract][Full Text] [Related]
42. Adenosine extracellular levels in human brain gliomas: an intraoperative microdialysis study.
Melani A; De Micheli E; Pinna G; Alfieri A; Corte LD; Pedata F
Neurosci Lett; 2003 Jul; 346(1-2):93-6. PubMed ID: 12850556
[TBL] [Abstract][Full Text] [Related]
43. Purinergic transmission in brain tumors and its impact on drug development.
Abbracchio M; Ceruti S; Lecca D
Springerplus; 2015; 4(Suppl 1):L10. PubMed ID: 27386173
[No Abstract] [Full Text] [Related]
44. Immunosuppression in Gliomas
Scheffel TB; Grave N; Vargas P; Diz FM; Rockenbach L; Morrone FB
Front Oncol; 2020; 10():617385. PubMed ID: 33659213
[TBL] [Abstract][Full Text] [Related]
45. CD73 Downregulation Decreases In Vitro and In Vivo Glioblastoma Growth.
Azambuja JH; Gelsleichter NE; Beckenkamp LR; Iser IC; Fernandes MC; Figueiró F; Battastini AMO; Scholl JN; de Oliveira FH; Spanevello RM; Sévigny J; Wink MR; Stefani MA; Teixeira HF; Braganhol E
Mol Neurobiol; 2019 May; 56(5):3260-3279. PubMed ID: 30117104
[TBL] [Abstract][Full Text] [Related]
46. Guanosine promotes cytotoxicity via adenosine receptors and induces apoptosis in temozolomide-treated A172 glioma cells.
Oliveira KA; Dal-Cim TA; Lopes FG; Nedel CB; Tasca CI
Purinergic Signal; 2017 Sep; 13(3):305-318. PubMed ID: 28536931
[TBL] [Abstract][Full Text] [Related]
47. Potentiation of temozolomide antitumor effect by purine receptor ligands able to restrain the in vitro growth of human glioblastoma stem cells.
D'Alimonte I; Nargi E; Zuccarini M; Lanuti P; Di Iorio P; Giuliani P; Ricci-Vitiani L; Pallini R; Caciagli F; Ciccarelli R
Purinergic Signal; 2015 Sep; 11(3):331-46. PubMed ID: 25976165
[TBL] [Abstract][Full Text] [Related]
48. Adenosine Signaling in Glioma Cells.
Ceruti S; Abbracchio MP
Adv Exp Med Biol; 2020; 1202():13-33. PubMed ID: 32034707
[TBL] [Abstract][Full Text] [Related]
49. Purinergic signaling in glioma progression.
Braganhol E; Wink MR; Lenz G; Battastini AM
Adv Exp Med Biol; 2013; 986():81-102. PubMed ID: 22879065
[TBL] [Abstract][Full Text] [Related]
50. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment.
Hoelzinger DB; Demuth T; Berens ME
J Natl Cancer Inst; 2007 Nov; 99(21):1583-93. PubMed ID: 17971532
[TBL] [Abstract][Full Text] [Related]
51. Signaling pathways regulating gliomagenesis.
Konopka G; Bonni A
Curr Mol Med; 2003 Feb; 3(1):73-84. PubMed ID: 12558076
[TBL] [Abstract][Full Text] [Related]
52. Suppression of Rac activity induces apoptosis of human glioma cells but not normal human astrocytes.
Senger DL; Tudan C; Guiot MC; Mazzoni IE; Molenkamp G; LeBlanc R; Antel J; Olivier A; Snipes GJ; Kaplan DR
Cancer Res; 2002 Apr; 62(7):2131-40. PubMed ID: 11929835
[TBL] [Abstract][Full Text] [Related]
53. Adenosine signaling in glioma cells.
Ceruti S; Abbracchio MP
Adv Exp Med Biol; 2013; 986():13-30. PubMed ID: 22879062
[TBL] [Abstract][Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
